Zepp Health Corporation

Technology · Consumer Electronics

3.90$ -0.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

Zepp Health Corporation (ZEPP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 434 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZEPP
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	56	90	48	72	71	753	92	119	158	1,225	119	152	265	2,111	156	160	323	1,973	177	284	248	1,662	119	168	176	151	94	92	83	84	289	295	298	433	280	427	540	598	356	434	1,927
Cost of Revenue	45	72	37	53	52	586	69	88	116	916	86	112	198	1,608	121	125	256	1,598	137	222	198	1,341	95	138	142	120	79	72	55	55	183	176	177	274	176	273	334	353	218	268	1,173
Gross Profit	11	18	11	19	19	167	23	31	42	309	32	41	67	503	35	36	66	375	40	62	50	321	24	30	34	31	15	20	28	29	106	119	121	159	104	155	206	245	138	165	754
Research & Development	5.5	5.0	5.9	4.8	5.3	45	12	7.0	8.8	85	11	14	18	140	17	17	25	130	24	25	17	94	23	20	19	16	17	13	10	11	97	79	76	80	90	80	77	77	77	79	310
Selling, General & Administrative	11	4.8	4.1	3.9	27	32	7.8	33	68	64	6.7	51	70	83	51	55	91	65	65	66	62	65	58	72	53	50	50	54	6.6	5.2	46	4.9	7.0	20	6.5	32	50	27	24	24	126
Total Operating Expenses	11	12	12	10	11	92	22	15	24	178	21	27	36	285	32	34	55	311	48	51	40	311	48	47	44	41	37	31	27	28	221	191	209	224	238	198	212	272	260	249	993
Operating Income	-0.3	6.3	-0.8	8.5	8.1	75	1.4	16	19	131	12	13	31	218	2.9	1.3	12	64	-7.7	11	9.7	10	-24	-17	-11	-10.0	-22	-10	1.5	0.6	-114	-72	-88	-65	-133	-44	-6.3	-27	-122	-84	-240
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	15	7.5	12	11	12	0.1	1.1	1.1	–	1.0	1.6	2.1	14	1.8	2.1	2.2	2.3	1.9	1.8	1.6	1.4	10	10.0	9.0	11	9.9	9.0	11	11	11	11	45
Pre-Tax Income	0.1	7.4	-0.7	8.5	8.6	80	2.6	16	20	139	13	15	33	237	2.9	2.3	13	133	-7.4	16	8.5	22	-17	-18	-7.4	-11	-24	-12	0.4	1.5	-106	-78	-93	-170	-143	-54	-11	-63	-134	-77	-284
Income Tax Expense	0.0	1.0	-0.1	1.2	1.1	12	0.4	2.5	3.1	12	1.6	1.8	3.9	27	0.3	0.4	1.2	18	-1.2	1.8	1.0	0.5	-2.6	-2.0	-4.9	-0.4	-3.6	-1.7	0.1	2.8	0.5	0.3	0.5	99	0.8	1.7	0.8	15	1.5	0.8	18
Net Income	0.0	6.3	-0.7	7.2	7.5	72	2.3	13	17	126	11	13	29	207	2.7	1.9	12	115	-6.2	14	7.6	36	-14	-16	-2.5	-11	-20	-10.0	0.4	-1.3	-107	-79	-93	-269	-143	-56	-12	-77	-136	-77	-301
EBITDA	0.1	7.4	-0.7	8.6	8.7	75	2.6	16	19	123	13	15	32	216	2.9	3.4	13	-0.5	-6.5	14	10	36	-15	-18	-5.7	-8.6	-21	-9.0	2.1	1.1	-92	-66	-81	-134	-130	-36	6.4	-51	-123	-84	-251

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings